New England Journal of Medicine study updates promising activity of Sacituzumab treatment for triple neg breast cancer.
Combination of precision cancer medicines may represent new treatment strategy for advanced renal cell cancer.
Keynote 054 clinical trial establishes Keytruda as standard treatment for stage III melanoma and leads to FDA approval.
Initial treatment with the Keytruda checkpoint inhibitor immunotherapy has become a standard of care for PD-1 + NSCLC.
Checkpoint inhibitor Inlyta combo heads to FDA approval-likely to become new standard treatment for renal cell cancer
Treatment of stages III - IV A or B Hodgkin lymphoma: Adcetris + ABV is the new standard of care.
Immunotherapy effective as treatment of melanoma spread to brain, researchers advocate combinations of drugs.
Margetuximab improves progression-free survival compared to Herceptin® in patients with HER2+ metastatic breast cancer.
First NET Center of Excellence Recognized:
Merkel Cell FDA Approves Keytruda
Update on polio virus clinical trial: UCSF;
Article sheds light on long term heart risks from chemotherapy:
John Hopkins Researchers develop new test to screen for esophageal cancer.
Curious if others have experience with Lartruvo working and are nervous about the new study results?
Harvard Study on Statins lowering risk of prostate cancer.
Great news - Cancer mortality rates continue to decline: what do you think is the biggest contributor?
Colon and lung cancer are increasing in young adults; start the year of right and make sure you get screened:
